Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia

American Journal of Infection Control

Volumn 32, Issue 3, 2004, Pages 135-141

  Rosenthal, Victor D ^a   Maki, Dennis G ^b,c,d  

^a Bernal Medical Center   (Argentina)

^b University of Wisconsin Health   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; COST CONTROL; FEMALE; HAND WASHING; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFUSION SYSTEM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PROSPECTIVE STUDY; RISK FACTOR; SOUTH AND CENTRAL AMERICA;

EID: 2442511212     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2003.12.002     Document Type: Article

References (62)

1. Haley RW, Morgan WM, Culver DH, White JW, Emori TG, Mosser J, et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control 1985;13:97-108.
2. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.
3. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996;24:262-77.
4. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program utilizing performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003;31:405-9.
5. Maki D, Mermel L. Infections due to infusion therapy. In: Bennett JV, Brachman PS, editors. Hospital infections. Philadelphia: Lippincott-Raven; 1998. p. 689-724.
6. Crnich CJ, Maki DG. The role of intravascular devices in sepsis. Curr Infect Dis Rep 2001;3:497-506.
7. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line associated blood stream infection in intensive care units in Argentina. A prospective, case control matched analysis. Am J Infect Control 2003;31:475-80.
8. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976-81.
9. Liu JW, Su YK, Liu CF, Chen JB. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect 2002;50:224-7.
10. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol 2000;21:375-80.
11. Goldmann DA, Maki DG, Rhame FS, Kaiser AB, Tenney JH, Bennett JV. Guidelines for infection control in intravenous therapy. Lamp 1979;36:4-6.
12. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:438-73.
13. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002;30:476-89.
14. Goldman DA, Maki DG, Rhame FS, Kaiser AB, Tenney JH, Bennett JV. Guidelines for infection control in intravenous therapy. Ann Intern Med 1973;79:848-50.
15. Goldmann DA, Maki DG. Infection control in total parenteral nutrition. JAMA 1973;223:1360-4.
16. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973;79:867-87.
17. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002;34:1232-42.
18. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 2002;34:1362-8.
19. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988;85:307-14.
20. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-43.
21. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987;258:2396-403.
22. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994;22:1729-37.
23. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431-6.
24. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127:257-66.
25. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis 1975;131:267-72.
26. Mackel DC, Maki DG, Anderson RL, Rhame FS, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products: mechanisms of intrinsic contamination. J Clin Microbiol 1975;2:486-97.
27. Maki DG, Rhame FS, Mackel DC, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. Am J Med 1976;60:471-85.
28. Goldmann DA, Dixon RE, Fulkerson CC, Maki DG, Martin SM, Bennett JV. The role of nationwide nosocomial infection surveillance in detecting epidemic bacteremia due to contaminated intravenous fluids. Am J Epidemiol 1978;108:207-13.
29. Munoz JM, Macias AE, Guerrero FJ, Hernandez I, Medina H, Vargas E. Control of pediatric nosocomial bacteremia by a program based on culturing of parenteral solutions in use [in Spanish]. Salud Publica Mex 1999;41:S32-7.
30. Macias AE, Munoz JM, Bruckner DA, Galvan A, Rodriquez AB, Guerrero FJ, et al. Parenteral infusions bacterial contamination in a multi-institutional survey in Mexico: considerations for nosocomial mortality. Am J Infect Control 1999;27:285-90.
31. Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications-Brazil, 1996. MMWR Morb Mortal Wkly Rep 1998;47:610-2.
32. Matsaniotis NS, Syriopoulou VP, Theodoridou MC, Tzanetou KG, Mostrou GI. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infect Control 1984;5:471-7.
33. McAllister JC, Buchanan EC, Skolaut MW. A comparison of the safety and efficiency of three intermittent intravenous therapy systems-the minibottle, the minibag and the inline burette. Am J Hosp Pharm 1974;31:961-7.
34. Goldmann DA, Maki DG. Contamination of fluid for parenteral nutrition [letter]. N Engl J Med 1974;290:1437-8.
35. Maki DG, Hassemer CA. Endemic rate of fluid contamination and related septicemia in arterial pressure monitoring. Am J Med 1981;70:733-8.
36. Maki DG, Anderson RL, Shulman JA. In-use contamination of intravenous infusion fluid. Appl Microbiol 1974;28:778-84.
37. Scheckler WE, Brimhall D, Buck AS, Farr BM, Friedman C, Garibaldi RA, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1998;19:114-24.
38. Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991;19:19-35.
39. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;(16):128-40.
40. Sherertz RJ. Surveillance for infections associated with vascular catheters. Infect Control Hosp Epidemiol 1996;17:746-52.
41. Balows A, Hausler WHS. Manual of clinical microbiology. Washington (DC): American Society for Microbiology; 1991.
42. Gaynes RP, Culver DH, Emori TG, Horan TC, Banerjee SN, Edwards JR, et al. The National Nosocomial Infections Surveillance System: plans for the 1990s and beyond. Am J Med 1991;91:116-20S.
43. Rosenthal VD, McCormick RD, Guzman S, Villamayor C, Orellano PW. Effect of education and performance feedback on handwashing: the benefit of administrative support in Argentinean hospitals. Am J Infect Control 2003;31:85-92.
44. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002;81:466-79.
45. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, and length of hospital stay of central line associated blood stream infection in intensive care units in Argentina. A prospective, matched analysis. Presented at the Annual Meeting of the Society for Health Care and Epidemiology of America (SHEA); April 2003; Arlington, Va.
46. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002;23:190-7.
47. Slonim AD, Kurtines HC, Sprague BM, Singh N. The costs associated with nosocomial bloodstream infections in the pediatric intensive care unit. Pediatr Crit Care Med 2001;2:170-4.
48. Slonim AD, Singh N. Nosocomial bloodstream infection and cost. Crit Care Med 2001;29:1849.
49. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001;136:229-34.
50. Orrett FA, Brooks PJ, Richardson EG. Nosocomial infections in a rural regional hospital in a developing country: infection rates by site, service, cost, and infection control practices. Infect Control Hosp Epidemiol 1998;19:136-40.
51. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996;17:552-7.
52. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-601.
53. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003;31:291-5.
54. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-30.
55. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994;161:374-8.
56. Pittet D, Wenzel R. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177-84.
57. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002;23:759-69.
58. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-8.
59. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med 1992;116:737-8.
60. Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project. Arch Intern Med 1994;154:1829-32.
61. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997;127:267-74.
62. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki D, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002;30:476-89.